Comment
doi: 10.1016/S0140-6736(03)13562-3.
ASCOT-LLA: questions about the benefits of atorvastatin
- PMID: 12801764
- DOI: 10.1016/S0140-6736(03)13562-3
Item in Clipboard
Comment
ASCOT-LLA: questions about the benefits of atorvastatin
Lancet.
.
No abstract available
Comment on
-
What are the odds at ASCOT today?Lancet. 2003 Apr 5;361(9364):1144-5. doi: 10.1016/s0140-6736(03)12977-7. Lancet. 2003. PMID: 12686031 No abstract available.
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.
Similar articles
-
ASCOT-LLA: questions about the benefits of atorvastatin.Lancet. 2003 Jun 7;361(9373):1986; author reply 1986-7. doi: 10.1016/S0140-6736(03)13560-X. Lancet. 2003. PMID: 12801762 No abstract available.
-
ASCOT-LLA: questions about the benefits of atorvastatin.Lancet. 2003 Jun 7;361(9373):1986; author reply 1986-7. doi: 10.1016/S0140-6736(03)13559-3. Lancet. 2003. PMID: 12801761 No abstract available.
-
ASCOT-LLA: questions about the benefits of atorvastatin.Lancet. 2003 Jun 7;361(9373):1985-6; author reply 1986-7. doi: 10.1016/s0140-6736(03)13558-1. Lancet. 2003. PMID: 12801760 No abstract available.
-
Cholesterol levels and the benefit of statins in heart failure.Hellenic J Cardiol. 2005 May-Jun;46(3):226-31. Hellenic J Cardiol. 2005. PMID: 15981559 Review. No abstract available.
-
Hypothesis: atorvastatin has pleiotropic effects that translate into early clinical benefits on cardiovascular disease.J Cardiovasc Pharmacol Ther. 2004 Mar;9(1):61-3. doi: 10.1177/107424840400900i109. J Cardiovasc Pharmacol Ther. 2004. PMID: 15094970 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
